Dow Pharmaceutical Solutions

Our excipients and active pharmaceutical ingredients are designed to help solve customer challenges and address some of the most pressing health challenges and medical trends today.

ACTIVE PHARMACEUTICAL INGREDIENTS AND EXCIPIENTS BY DOW

Dow Pharma Solutions designs differentiated solutions that enable pharmaceutical delivery and help address some of the most pressing health challenges and medical trends today. A business of Dow Consumer Care, Dow Pharma Solutions offers a single interface to all Dow technologies and expertise focused on solutions serving the pharmaceutical markets. Thanks to decades of experience in the pharmaceutical industry, Dow has a proven track record working with customers around the globe to successfully develop approved functional excipients and active pharmaceutical ingredients (APIs) to help patients live healthier and more convenient lives.

NEWS, STORIES, AND EVENTS

With decades of technical and industry expertise, Dow Pharma Solutions – a business unit of the DowDuPont Specialty Products Division – addresses the toughest challenges its customers face in pharmaceutical applications, drug delivery systems and productivity enhancement. At CPhI Worldwide, Oct. 24-26, the business will share the latest excipient solutions at booth #102A50.
Read More

Dow Pharma & Food Solutions today announced the official global launch and commercial availability of ETHOCEL™ High Productivity (HP) a high productivity ethylcellulose polymer for multiparticulate and taste-
masking applications, designed specifically for use with rotor coater systems.
Read More

Dow and Colorcon Extend and Broaden the Scope of the Controlled Release Alliance

Colorcon Inc. and The Dow Chemical Company announced an agreement to broaden the existing
Controlled Release Alliance between the two companies
Read More

Dow Pharma & Food Solutions, a business unit of The Dow Chemical Company (NYSE: DOW) and Dow Corning, a wholly owned subsidiary of Dow, present latest innovations designed to address pharmaceutical
industry needs at CPhI Worldwide, in Barcelona (Spain), October 4-6 2016.
Read More

Influence of AFFINISOL™ viscosity on HME processability and drug release

Four grades of AFFINISOL™ HPMC HME were synthesized to specific target viscosities to first assess the
ability to control the dissolution rate of a poorly soluble API using itraconazole (ITZ) as a model drug. These four grades were then used to prepare polymer blends to determine the influence of apparent viscosity on HME processing and ASD dissolution performance.
Read More

In this study amorphous solid dispersions of ritonavir (RTV) were prepared by hot melt extrusion using the polymeric carriers AFFINISOL™ HPMC HME and copovidone at 3 different drug loads (25%, 33% and 50% w/w RTV). The resulting solid dispersions were placed in accelerated stability testing conditions for 6 months.
Read More

Improving Productivity through Innovation

Learn about ETHOCEL™ High Productivity - a new high productivity ethylcellulose polymer for multiparticulate and taste-masking applications that can help pharmaceutical companies to dry-coat barrier membranes in shorter coating times without the need for organic solvents.
Read More

Dow and Dow Corning are presenting their latest innovative technologies and breakthroughs for the pharmaceutical industry here at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition.
Read More

®™ Trademark of The Dow Chemical Company ("Dow") or an affiliated company of Dow

This website uses cookies to provide you the best experience. By clicking the “Accept” button below, you are consenting to receive and store cookies from our site. Remember, you can manage cookies in your browser’s settings. If you do not accept the deployment of cookies or restrict them in any way, you will not be able to use all the interactive functions on our website. For more information about our use of cookies, please view our Privacy Policy